Observational study of bispectral index monitoring as an adjunct to dexmedetomidine deep sedation for endoscopic treatment

Observational study of bispectral index monitoring as an adjunct to dexmedetomidine deep sedation for endoscopic treatment - Observational study of bispectral index monitoring as an adjunct to dexmedetomidine deep sedation for endoscopic treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042125

Enrollment

Registered

2020-10-14

Start date

2020-10-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient undergoing endoscopic treatment for the gastrointesitinal tumor under the dexmedetomidine sedation

Exclusion criteria

Exclusion criteria: examinees who is considered ungrammaticaly by the endoscopists

Design outcomes

Primary

Measure	Time frame
the score of Bispectral Index System between 4 to 6 in Ramsay sedation scale and -3 to -5 in Richmond Agitation-Sedation Scale under the dexmedetomidine sedation	—

Countries

Japan

Contacts

Public ContactYasutoshi Ochiai

St. Marianna University, School of Medicine Toyoko Hospital Department of Gastroenterology

yasutoshi.ochiai@marianna-u.ac.jp0447222121

Outcome results